Matches in Wikidata for { <http://www.wikidata.org/entity/Q89155212> ?p ?o ?g. }
Showing items 1 to 37 of
37
with 100 items per page.
- Q89155212 description "clinical trial" @default.
- Q89155212 description "ensayu clínicu" @default.
- Q89155212 description "klinisch onderzoek" @default.
- Q89155212 description "клінічне випробування" @default.
- Q89155212 name "Bioequivalence (BE) Study of Test Griseofulvin 500 Milligram (mg) Tablets Versus Reference and Dose Proportionality Study of Test Griseofulvin 250 mg and 500 mg Tablets Under Fed Conditions" @default.
- Q89155212 name "Bioequivalence (BE) Study of Test Griseofulvin 500 Milligram (mg) Tablets Versus Reference and Dose Proportionality Study of Test Griseofulvin 250 mg and 500 mg Tablets Under Fed Conditions" @default.
- Q89155212 type Item @default.
- Q89155212 label "Bioequivalence (BE) Study of Test Griseofulvin 500 Milligram (mg) Tablets Versus Reference and Dose Proportionality Study of Test Griseofulvin 250 mg and 500 mg Tablets Under Fed Conditions" @default.
- Q89155212 label "Bioequivalence (BE) Study of Test Griseofulvin 500 Milligram (mg) Tablets Versus Reference and Dose Proportionality Study of Test Griseofulvin 250 mg and 500 mg Tablets Under Fed Conditions" @default.
- Q89155212 prefLabel "Bioequivalence (BE) Study of Test Griseofulvin 500 Milligram (mg) Tablets Versus Reference and Dose Proportionality Study of Test Griseofulvin 250 mg and 500 mg Tablets Under Fed Conditions" @default.
- Q89155212 prefLabel "Bioequivalence (BE) Study of Test Griseofulvin 500 Milligram (mg) Tablets Versus Reference and Dose Proportionality Study of Test Griseofulvin 250 mg and 500 mg Tablets Under Fed Conditions" @default.
- Q89155212 P1132 Q89155212-EF658698-0CBD-4B65-B154-BEA6E3EBC1F0 @default.
- Q89155212 P1476 Q89155212-F84ED9A5-2C8E-4455-AC6C-885D6C2BAFF5 @default.
- Q89155212 P17 Q89155212-C7ADE551-BCD5-40EE-8D48-8251FDDE8B5E @default.
- Q89155212 P2899 Q89155212-8E18A616-704E-4941-A4EB-14C67B45CB42 @default.
- Q89155212 P3098 Q89155212-A08A5C73-1BAC-4468-B755-B2338B110961 @default.
- Q89155212 P31 Q89155212-4FE47A92-E3ED-4434-A5CE-CB0D8BB3A0FA @default.
- Q89155212 P4135 Q89155212-20A63B31-B0AB-4353-9C18-3C13975AAE42 @default.
- Q89155212 P4844 Q89155212-7462B81A-B51D-4171-AB52-379C167D37A9 @default.
- Q89155212 P580 Q89155212-A85F3FAB-10D7-4B64-8444-A34301206F39 @default.
- Q89155212 P582 Q89155212-ED019997-BDF0-458D-BD0C-01A88561A0E5 @default.
- Q89155212 P6099 Q89155212-1DB5CA22-552F-4739-828B-C0F61DD71612 @default.
- Q89155212 P8363 Q89155212-83B82F51-6114-450D-B740-746FF086870B @default.
- Q89155212 P859 Q89155212-57C9DF60-404B-4D96-B5B8-1776B4B631D4 @default.
- Q89155212 P1132 "+36" @default.
- Q89155212 P1476 "An Open Label, Randomized, Balanced, Three Treatment, Three Period, Three Sequence, Single Dose, Crossover Study to Evaluate the Bioequivalence of Test Griseofulvin Tablets, 500 mg Versus Reference Griseofulvin Tablets, 500 mg as Well as Dose Proportionality of Test Griseofulvin Tablets, 250 mg and 500 mg, in Healthy, Adult Participants Under Fed Conditions" @default.
- Q89155212 P17 Q668 @default.
- Q89155212 P2899 "+18" @default.
- Q89155212 P3098 "NCT04318535" @default.
- Q89155212 P31 Q30612 @default.
- Q89155212 P4135 "+45" @default.
- Q89155212 P4844 Q416096 @default.
- Q89155212 P580 "2020-01-13T00:00:00Z" @default.
- Q89155212 P582 "2020-01-13T00:00:00Z" @default.
- Q89155212 P6099 Q5452194 @default.
- Q89155212 P8363 Q78089383 @default.
- Q89155212 P859 Q212322 @default.